Our 10 Year Plan
Merrimac Pharmacy & NCC
A comprehensive overview of business operations, strategic vision, and growth trajectory for our integrated pharmacy and healthcare services
Business Operating System
In 2023, NCC Health made a transformative decision to implement the Entrepreneurial Operating System (EOS), a comprehensive business management framework designed to help growing companies achieve their vision with greater discipline and accountability.
Team Structure
Implement a clear organizational framework with defined roles and responsibilities
Self-Accountability
Enable all team members to take ownership of their goals and performance
Meeting Rhythms
Introduce regular, structured meeting cadences for alignment and progress tracking
Growth Path
Create a clear trajectory with measurable KPIs to enable sustainable expansion
EOS System
A Framework for Strategic Excellence
Strategic Foundation
The EOS framework provides a comprehensive structure that cascades from our core identity down to daily execution, ensuring alignment at every level.
- Core Values that define our culture
- Business Focus encompassing Vision, Mission, Promise, and Niche
- BHAG – Big Hairy Audacious Goal to inspire long-term thinking
Execution Framework
Our planning horizons and rhythms create accountability and momentum:
- 3-Year Vision for strategic direction
- 1-Year Goals for focused objectives
- Quarterly Goals for tactical execution
Meeting Rhythms: Daily huddles, weekly team meetings, monthly Management meetings, quarterly reviews, and annual planning sessions
Core Values
The Foundation of Our Culture
Our core values define who we are, guide how we work, and shape the culture we cultivate every day. These principles are non-negotiable standards that every team member embodies in their daily actions and decision-making.
These values serve as our compass for hiring, performance evaluation, and strategic decision-making. They ensure we maintain consistency in how we serve our customers, support our team members, and grow our business with integrity and purpose.
Vision, Mission, Promise
Our Strategic Identity
These three elements form the cornerstone of our business identity. Our Vision defines where we're going and what we aspire to become. Our Mission articulates why we exist and the impact we create for our customers and community. Our Promise represents the commitment we make to every stakeholder—patients, healthcare providers, and team members—ensuring they know exactly what to expect when they engage with NCC Health.
BHAG: Big, Hairy, Audacious Goal
10 Years from Now – 2032
Advanced Healthcare Business
By 2032, NCC Health will transform into a diversified advanced healthcare enterprise, expanding beyond traditional pharmacy services into comprehensive healthcare solutions. Our ambitious 10-year vision encompasses seven distinct business divisions, each contributing to our goal of becoming 10X the size of our 2023 operations.
1
NCC Health
Parent company overseeing all divisions
2
Merrimac Pharmacy
Leading Gold Coast pharmacy servicing multiple telehealth & RACF facilities
3
NCC Manufacturing
TGA-approved cGMP manufacturer of compounded medicines
4
NCC Compounding
Australia's leading B2C and B2B compounding provider
5
NCC Sterile
Sterile medicine provider to patients, clinics, and hospitals
6
NCC Technology
Leading SAAS platform for compounding pharmacies
7
NCC Analytical
NATA-accredited analytical laboratory serving NCC and external customers
BHAG: 2032 Vision Statement
We are a leading healthcare business, offering service through a community pharmacy and complex compounding pharmacy. We produce sterile and non-sterile medicines for patients and medical practitioners throughout Australia.
B2B Healthcare Leadership
We are engaging in extensive B2B work with private and public hospitals, commanding more than 50% market share for B2B compounding via community pharmacies across Australia.
Cutting-Edge Production
Our advanced technology and streamlined compounding production process enables us to offer a 24-hour 'made' guarantee for all customers—a revolutionary standard in pharmaceutical compounding.
This vision positions us at the forefront of Australia's healthcare landscape, combining community pharmacy accessibility with advanced pharmaceutical manufacturing capabilities and technological innovation that sets new industry benchmarks.
3-Year Plan – 2026
Strategic Milestones and Expansion
NCC.health – Head Company
Network Expansion: 1,500 affiliate pharmacies throughout Australia
Geographic Reach: Sterile operations throughout VIC, NSW, QLD, expanding into sterile hospital products
Regulatory Achievement: TGA compounding license in-progress with QA team managing application
Quality Systems: Quality Management System (QMS) fully implemented and operational
Laboratory Services: NCC Analytical operational, serving NCC and external compounding pharmacies
Merrimac Pharmacy
Healthcare Partnerships: Servicing telehealth facilities
Medical Integration: Operating alongside a busy adjacent medical center for seamless patient care
Digital Commerce: Online store generating more than 10% of total retail sales, representing significant digital transformation
3-Year Plan – 2026
Financial and Operational Targets
NCC Performance Metrics
Annual Sales: $6.5M with 25% year-on-year growth trajectory
Daily Production: 350 compounds per day, 140 lab items per day
Team Size: Full-time team of approximately 30-35 professionals
Merrimac Pharmacy Performance Metrics
Annual Sales: $3.3M with steady 10% year-on-year growth
Daily Operations: 115 retail items per day, 160 prescriptions per day
Team Size: Full-time team of approximately 6-7 staff members
Current Financials – FY 2023
NCC Performance and Growth
$3.5M
Annual Sales
22% year-on-year growth demonstrating strong market demand
735
Affiliate Businesses
Plus 3 large customers generating >$200K sales per year
195
Daily Compounds
Average compounded items sold per day
78
Lab Items Daily
Average laboratory items manufactured per day
Monthly Expenses
$91,200 – Representing a 162% increase from the previous year, reflecting significant infrastructure investments and operational scaling to support rapid growth
Monthly Wage Costs
$99,637 – An 11% increase from the previous year, demonstrating controlled labor cost management despite substantial business expansion
Current Financials – FY 2023
MP Performance and Growth
76%
Dispensary Revenue
$1.9M from prescription services
20%
Retail Revenue
$0.5M from retail sales
MP achieved $2.5M in annual sales, representing a robust 21% increase from the previous year. This growth reflects our strengthening position in the local community and effective integration of dispensary and retail operations.
Daily Operations
125 prescriptions dispensed
72 retail customers served
Monthly Expenses
$26,847 (7% increase)
Controlled cost management
Monthly Wage Costs
$26,000 (34% increase)
Strategic staffing investments
1-Year Goals – FY 2024
NCC Strategic Targets
Revenue Target
$4.375M Annual Sales
25% growth on prior year, maintaining aggressive expansion trajectory
Production Volume
247 compounds daily
98 lab items daily
Scaling operations to meet growing market demand
Network Growth
900 affiliate businesses
5 large customers (>$200K per year)
Expanding market reach and key partnerships
Cost Management
Monthly Expenses: Maintained at similar levels to prior year through operational efficiency improvements
Workforce Scaling
Monthly Wages: 5% increase to support higher production volumes while maintaining productivity ratios
1-Year Goals – FY 2024
MP Strategic Targets
MP is targeting $2.75M in annual sales, representing a solid 10% increase from FY 2023. This measured growth strategy reflects our commitment to sustainable expansion while maintaining service quality and operational excellence.
Daily Operations Target
140 prescriptions dispensed per day (12% increase)
80 retail customers served per day (11% increase)
Cost Stability
Monthly Expenses: Maintained at similar levels to prior year
Monthly Wage Costs: Maintained at current levels through efficiency gains
Our focus remains on optimizing existing operations, deepening community relationships, and leveraging our adjacent medical center partnership to drive organic growth without significant cost increases.